According to a study, among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance. The study appeared in the March 27 issue of iJAMA/i. David J. Serisier, M.B.B.S., D.M., F.R.A.C.P., of Mater Adult Hospital, South Brisbane, Australia, and colleagues tested the hypothesis that low-dose erythromycin would reduce pulmonary ...Friday, 29 March 2013
Antibiotic may Provide Benefit for Treatment of Respiratory Disorder: Study
According to a study, among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance. The study appeared in the March 27 issue of iJAMA/i. David J. Serisier, M.B.B.S., D.M., F.R.A.C.P., of Mater Adult Hospital, South Brisbane, Australia, and colleagues tested the hypothesis that low-dose erythromycin would reduce pulmonary ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment